Tekijä: Carlos Lopez (ed.); Ryoichi Mori (ed.); Bernard Roizman (ed.); Richard J. Whitley (ed.) Kustantaja: Springer (2012) Saatavuus: Noin 17-20 arkipäivää
Tekijä: Victor Manuel López Sánchez (ed.); Francisco Gaudêncio Mendonça Freires (ed.); João Carlos Gonçalves dos Reis (ed.); Costa Ma Kustantaja: Springer (2022) Saatavuus: Noin 17-20 arkipäivää
Tekijä: Francisco J. Martínez-López (ed.); Juan Carlos Gázquez-Abad (ed.); Raj Sethuraman (ed.) Kustantaja: Springer (2015) Saatavuus: Noin 17-20 arkipäivää
Tekijä: Francisco J. Martínez-López (ed.); Juan Carlos Gázquez-Abad (ed.); Kusum L. Ailawadi (ed.); María Jesús Yagüe-Guillén (ed.) Kustantaja: Springer (2017) Saatavuus: Noin 17-20 arkipäivää
Tekijä: Juan Carlos Figueroa-García (ed.); Eduyn Ramiro López-Santana (ed.); José Luis Villa-Ramírez (ed.); Roberto (e Ferro-Escobar Kustantaja: Springer (2017) Saatavuus: Noin 17-20 arkipäivää
Tekijä: Juan Carlos Gázquez-Abad (ed.); Francisco J. Martínez-López (ed.); Irene Esteban-Millat (ed.); Juan Antonio Mondéjar-Jiménez Kustantaja: Springer (2014) Saatavuus: Noin 17-20 arkipäivää
Tekijä: Juan Carlos Figueroa-García (ed.); Eduyn Ramiro López-Santana (ed.); José Ignacio Rodriguez-Molano (ed.) Kustantaja: Springer (2018) Saatavuus: Noin 17-20 arkipäivää
Tekijä: Francisco J. Martínez-López (ed.); Juan Carlos Gázquez-Abad (ed.); Anne Roggeveen (ed.) Kustantaja: Springer (2019) Saatavuus: Noin 17-20 arkipäivää
Tekijä: Francisco J. Martinez-Lopez (ed.); Juan Carlos Gázquez-Abad (ed.); Els Breugelmans (ed.) Kustantaja: Springer (2020) Saatavuus: Noin 17-20 arkipäivää
Tekijä: Álvaro Rocha (ed.); Paulo Carlos López-López (ed.); Juan Pablo Salgado-Guerrero (ed.) Kustantaja: Springer (2022) Saatavuus: Noin 17-20 arkipäivää
Springer Sivumäärä: 314 sivua Asu: Kovakantinen kirja Painos: 2009 Julkaisuvuosi: 2009, 25.06.2009 (lisätietoa) Kieli: Englanti
It is now over ten years since we edited the first edition of HLA-B27 in the Development of Spondyloarthropathies (SpA). It is obvious that over this period an enormous amount of information concerning SpA and HLA-B27 has accumulated, and this has been reflected in the knowledge of molecular mechanism of the spondyloarthropathies. Discussion for such a book took initial form at the outstanding 4th Gent Symposium on SpA in October 2006, but was not formally commissioned by Landes Bioscience until early 2007. Molecular Mechanisms of Spondyloarthropathies aims to synthesize this growing knowledge and present all the current studies concerning the basic research of SpA.
Over the last decade, enormous progress has been made in the understanding of the molecular and cellular processes that lead to disease pathology. Recognition of the pathways involved in the pathogenic mechanisms of disease and the potential to target specific immune effector functions have opened the door to a wide range of innovative treatment opportunities for the SpA. Thus, we believe that the understanding of the specific molecular mechanisms involved would help to design highly specific drugs in the future. The contributors are among the best in their field and reflect the state of the art of research and current opinion of rheumatologists and immunologists.
